investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Tumor Heterogeneity and Acquired Resistance to EGFR Inhibition
Scott Kopetz
5 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Hagen Kennecke
Vancouver Hospital and Health Sciences Centre
Vancouver, Canada
BC Cancer Agency
Vancouver, Canada
Stanley Hamilton
University of Texas MD Anderson Cancer Center
Houston, United States
Jeffrey Morris
University of Texas MD Anderson Cancer Center
Houston, United States
Edmund Kopetz
University of Texas MD Anderson Cancer Center
Houston, United States
Brian James
Sanford-Burnham Medical Research Institute
La Jolla, United States
Scott Kopetz
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Louis-Bastien Weiswald
Role of CDK10 in colorectal cancer
Colorectum
David Salomon
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Colorectum
Kevin Michael Haigis
Basic and Translational studies of Ras-mutant colorectal cancer
Colorectum
Brian D Dynlacht
Targeted Screen for Novel Chemical Modulators of Wnt/Beta-Cat Signaling Pathway.
Colorectum
Dana Pe'Er
Integrative Cancer Genomics: Drivers, Pathways and Drugs
Colorectum
Christopher I Li
Discovery and verification of novel biomarkers of colorectal cancer recurrence
Colorectum
Pathology
Marianne Sadar
Reversible inhibitors of the N-terminal domain of the androgen receptor
Colorectum
Julie Secombe
Distinct Modes of Gene Regulation by KDM5
Colorectum
David FitzGerald
Bio-Therapies for the Treatment of Cancer
Colorectum
